These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 23348585

  • 1. Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms.
    Charette N, De Saeger C, Horsmans Y, Leclercq I, Stärkel P.
    Cell Death Dis; 2013 Jan 24; 4(1):e471. PubMed ID: 23348585
    [Abstract] [Full Text] [Related]

  • 2. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Charette N, De Saeger C, Lannoy V, Horsmans Y, Leclercq I, Stärkel P.
    Mol Cancer; 2010 Sep 22; 9():256. PubMed ID: 20860815
    [Abstract] [Full Text] [Related]

  • 3. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T.
    J Chemother; 2017 Jun 22; 29(3):179-188. PubMed ID: 28067150
    [Abstract] [Full Text] [Related]

  • 4. TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.
    Jang JY, Kim SJ, Cho EK, Jeong SW, Park EJ, Lee WC, Lee SH, Kim SG, Kim YS, Kim HS, Kim BS, Lin W, Chung RT.
    PLoS One; 2014 Jun 22; 9(6):e98171. PubMed ID: 24927176
    [Abstract] [Full Text] [Related]

  • 5. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5.
    Kang YJ, Kim IY, Kim EH, Yoon MJ, Kim SU, Kwon TK, Choi KS.
    Exp Mol Med; 2011 Jan 31; 43(1):24-34. PubMed ID: 21150246
    [Abstract] [Full Text] [Related]

  • 6. YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
    Pennati M, Sbarra S, De Cesare M, Lopergolo A, Locatelli SL, Campi E, Daidone MG, Carlo-Stella C, Gianni AM, Zaffaroni N.
    Int J Cancer; 2015 Jan 15; 136(2):299-309. PubMed ID: 24866585
    [Abstract] [Full Text] [Related]

  • 7. Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.
    Premkumar DR, Jane EP, Foster KA, Pollack IF.
    J Pharmacol Exp Ther; 2013 Aug 15; 346(2):201-10. PubMed ID: 23740602
    [Abstract] [Full Text] [Related]

  • 8. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG, Choi YH, Hyun JW, Kim GY.
    Environ Toxicol Pharmacol; 2014 Nov 15; 38(3):959-67. PubMed ID: 25461556
    [Abstract] [Full Text] [Related]

  • 9. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 10. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

  • 11. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF, Cao JG, Tian L, Liu F.
    Cancer Chemother Pharmacol; 2012 Jan 20; 69(1):195-206. PubMed ID: 21660448
    [Abstract] [Full Text] [Related]

  • 12. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct 20; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 13. α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation.
    Mota A, Jiménez-Garcia L, Herránz S, de Las Heras B, Hortelano S.
    Toxicol Appl Pharmacol; 2015 Aug 01; 286(3):168-77. PubMed ID: 25930665
    [Abstract] [Full Text] [Related]

  • 14. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C, Qi R, Li N, Wang Z, An H, Zhang Q, Yu Y, Cao X.
    J Biol Chem; 2009 Jun 12; 284(24):16183-16190. PubMed ID: 19376776
    [Abstract] [Full Text] [Related]

  • 15. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS.
    Carcinogenesis; 2010 Mar 12; 31(3):367-75. PubMed ID: 19939880
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
    Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB, Huang MS.
    Oncol Rep; 2011 Feb 12; 25(2):461-8. PubMed ID: 21152876
    [Abstract] [Full Text] [Related]

  • 17. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
    He SQ, Chen Y, Chen XP, Zhang WG, Wang HP, Zhang BX.
    Zhonghua Wai Ke Za Zhi; 2003 Jun 12; 41(6):453-7. PubMed ID: 12895357
    [Abstract] [Full Text] [Related]

  • 18. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY, Jung KH, Morgan MJ, Kang YR, Lee HS, Koo GB, Hong SS, Kwon SW, Kim YS.
    Mol Cancer Ther; 2013 Mar 12; 12(3):274-85. PubMed ID: 23053497
    [Abstract] [Full Text] [Related]

  • 19. Nutlin-3 Promotes TRAIL-Induced Liver Cancer Cells Apoptosis by Activating p53 to Inhibit bcl-2 and Surviving Expression.
    Zhang C, Ni J, Fan W, Hou J.
    Ann Clin Lab Sci; 2022 Jul 12; 52(4):601-610. PubMed ID: 36197780
    [Abstract] [Full Text] [Related]

  • 20. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E, Zydowicz G, Mizgala E, Krol W.
    Int J Oncol; 2012 Sep 12; 41(3):818-28. PubMed ID: 22735465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.